Research ArticleDrug Discovery and Translational Medicine
PECAM targeted oxidant-resistant mutant thrombomodulin fusion protein with enhanced potency in vitro and vivo
Ronald Carnemolla, Colin F Greineder, Ann Marie Chacko, Kruti R Patel, Bi-Sen Ding, Sergei Zaytsev, Charles T Esmon and Vladimir R Muzykantov
Journal of Pharmacology and Experimental Therapeutics August 21, 2013, jpet.113.205104; DOI: https://doi.org/10.1124/jpet.113.205104
Ronald Carnemolla
1 University of Pennsylvania;
Colin F Greineder
2 Univeristy of Pennsylvania;
Ann Marie Chacko
1 University of Pennsylvania;
Kruti R Patel
3 Boston University;
Bi-Sen Ding
4 Weill Medical College;
Sergei Zaytsev
1 University of Pennsylvania;
Charles T Esmon
5 Oklahoma Medical Research Foundation
Vladimir R Muzykantov
1 University of Pennsylvania;
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleDrug Discovery and Translational Medicine
PECAM targeted oxidant-resistant mutant thrombomodulin fusion protein with enhanced potency in vitro and vivo
Ronald Carnemolla, Colin F Greineder, Ann Marie Chacko, Kruti R Patel, Bi-Sen Ding, Sergei Zaytsev, Charles T Esmon and Vladimir R Muzykantov
Journal of Pharmacology and Experimental Therapeutics August 21, 2013, jpet.113.205104; DOI: https://doi.org/10.1124/jpet.113.205104
Research ArticleDrug Discovery and Translational Medicine
PECAM targeted oxidant-resistant mutant thrombomodulin fusion protein with enhanced potency in vitro and vivo
Ronald Carnemolla, Colin F Greineder, Ann Marie Chacko, Kruti R Patel, Bi-Sen Ding, Sergei Zaytsev, Charles T Esmon and Vladimir R Muzykantov
Journal of Pharmacology and Experimental Therapeutics August 21, 2013, jpet.113.205104; DOI: https://doi.org/10.1124/jpet.113.205104
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement